Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Parmiani

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigensDiego Tosi, Roberta Valenti, Agata Cova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccinePaola Filipazzi, Roberta Valenti, Veronica Huber, et al.
Cancer Research|April 3, 2003
Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analoguesMatteo G Carrabba, Chiara Castelli, Markus J Maeurer, et al.
European Journal of Immunology|March 21, 2003
Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID miceFrancesco Lozupone, Licia Rivoltini, Francesca Luciani, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Awareness and understanding of cancer immunotherapy in EuropeHåkan Mellstedt, Gustav Gaudernack, Winald R Gerritsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 28, 2010
LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sitesChiara Camisaschi, Chiara Casati, Francesca Rini, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2003
Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancerChiara Castelli, Licia Rivoltini, Francesca Rini, et al.
International Journal of Cancer|February 23, 2007
Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patientsMaria Daniotti, Viviana Vallacchi, Licia Rivoltini, et al.
Dermatology (Basel, Switzerland)|June 6, 2013
Surgical treatment of melanoma: a survey of Italian hospitalsAlessandro Testori, Vanna Chiarion-Sileni, Ignazio Stanganelli, et al.
The American Journal of Pathology|April 12, 2002
Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial functionPaola Matarrese, Luigi Di Biase, Laura Santodonato, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigensDiego Tosi, Roberta Valenti, Agata Cova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccinePaola Filipazzi, Roberta Valenti, Veronica Huber, et al.
Cancer Research|April 3, 2003
Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analoguesMatteo G Carrabba, Chiara Castelli, Markus J Maeurer, et al.
European Journal of Immunology|March 21, 2003
Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID miceFrancesco Lozupone, Licia Rivoltini, Francesca Luciani, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Awareness and understanding of cancer immunotherapy in EuropeHåkan Mellstedt, Gustav Gaudernack, Winald R Gerritsen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 28, 2010
LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sitesChiara Camisaschi, Chiara Casati, Francesca Rini, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2003
Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancerChiara Castelli, Licia Rivoltini, Francesca Rini, et al.
International Journal of Cancer|February 23, 2007
Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patientsMaria Daniotti, Viviana Vallacchi, Licia Rivoltini, et al.
Dermatology (Basel, Switzerland)|June 6, 2013
Surgical treatment of melanoma: a survey of Italian hospitalsAlessandro Testori, Vanna Chiarion-Sileni, Ignazio Stanganelli, et al.
The American Journal of Pathology|April 12, 2002
Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial functionPaola Matarrese, Luigi Di Biase, Laura Santodonato, et al.
Pageof 11